BiotechTube
Home/Stamford Pharmaceuticals/Michael Derby, MS, MBA
MD

Michael Derby, MS, MBA

Non-Executive Director

Stamford Pharmaceuticals

Therapeutic Areas

OncologyDermatological Oncology

Stamford Pharmaceuticals Pipeline

DrugIndicationPhase
SP-002Basal Cell Carcinoma (Multi-lesional)Phase 2
SP-537Pancreatic CancerPreclinical
SP-563Non-Muscle Invasive Bladder CancerPreclinical

Leadership Team at Stamford Pharmaceuticals

DC
Dr. Clement Leong, PhD, MBA
Chief Executive Officer and Director
ML
Michael Lamprecht, PhD
Director
DE
Dr. Edward McKenna, PharmD
Non-Executive Director
View full Stamford Pharmaceuticals profile